|
|
|
|
Vol. 55, Issue 5, 938-947, May 1999
Program of Molecular Pharmacology, Fred Hutchinson Cancer Research
Center, Seattle, Washington (B.J.M., M.A.I., C.M., J.P., C.O., M.M.C.);
the Fox Chase Cancer Center, Philadelphia, Pennsylvania (S.W.J.); and
Department of Radiation Oncology, University of Washington, Seattle,
Washington (J.S.R.)
Multicellular contact has been shown to influence the in vitro
sensitivity of cells to drug treatment. We investigated the use of
macroporous gelatin microcarriers, CultiSpher-G, as a convenient laboratory system for the molecular analysis of this "contact effect". We determined that human A549 cells can be grown in
CultiSphers with growth and cell cycle parameters similar to those of
monolayers. In addition, cells in CultiSphers express less p27/kip1, an
indicator of cell cycle arrest, than equivalent cells in monolayers.
When treated with drugs, A549 cells grown in CultiSphers or monolayers accumulate equivalent amounts of platinum-DNA adducts and similar amounts of doxorubicin. Moreover, A549 and KB-3-1 cells in CultiSphers have significantly decreased sensitivity to
cis-platinum(II)diammine dichloride (cisplatin),
4-hydroperoxycyclophosphamide, doxorubicin, and paclitaxel (taxol)
compared with cells in monolayers when assayed by clonogenic survival.
Cisplatin treatment in monolayers or CultiSphers did not result in
apoptotic cell death. In contrast, paclitaxel caused a significant
amount of sub-G1 DNA, an indicator of apoptosis, which was
diminished when cells were grown in CultiSphers compared with
monolayers. When grown in CultiSphers, cells with abrogated p53
function (A549/16E6 and NCI-H1299) were less sensitive to cisplatin
than the corresponding monolayer cells, indicating that the decrease in
sensitivity is p53 independent. Taken together, the data suggest that
CultiSpher-G microcarriers are a useful in vitro system to examine the
effects of three-dimensional cell contact on drug sensitivity of human
tumor cells.